Basic Information
LncRNA/CircRNA Name | LINC00518 |
Synonyms | NA |
Region | GRCh38_6:10429255-10434874 |
Ensemble | ENSG00000183674 |
Refseq | NR_027793 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR, Western blot, Luciferase reporter assay, RIP, etc. |
Sample | BC tissues, Human normal breast epithelial cell line HBL-100 and human BC epithelial cell lines MCF-7, MDA-MB-231 and MDA-MB-4359 |
Expression Pattern | up-regulated |
Function Description | The lincRNA expression data related to BC downloaded from the TCGA database revealed that there was a high expression of LINC00518 in BC, and a negative correlation between LINC00518 and CDX2. In addition, LINC00518 promotes CDX2 methylation by recruiting DNA methyltransferase through activating the Wnt signaling pathway. The down-regulation of LINC00518 inhibited proliferation, invasion, migration, and EMT of BC epithelial cells while enhancing apoptosis. The inhibitory effects of LINC00518 down-regulation was reversed by CDX2 down-regulation. In conclusion, our findings revealed that down-regulation of LINC00518 might have the ability to suppress BC progression by up-regulating CDX2 expression through the reduction of methylation and blockade of the Wnt signaling pathway, resulting in the inhibition of proliferation and promotion of apoptosis of BC epithelial cells. |
Pubmed ID | 30611858 |
Year | 2019 |
Title | Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway. |
External Links
Links for LINC00518 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |